Last reviewed · How we verify
Euglycemic clamp with Humalog® and Lantus®
Euglycemic clamp with Humalog® and Lantus® is a Small molecule drug developed by Adocia. It is currently in Phase 1 development.
At a glance
| Generic name | Euglycemic clamp with Humalog® and Lantus® |
|---|---|
| Sponsor | Adocia |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Trial Investigating the Pharmacodynamics of BC Combo THDB0207 Compared With Humalog® Mix25 and Simultaneous Injections of Humalog® and Lantus® in Healthy Chinese Volunteers (PHASE1)
- A Trial Comparing the Pharmacodynamics and Pharmacokinetics of BC Combo THDB0207 and Lantus® and Humalog® in Subjects With Type 1 Diabetes (PHASE1)
- Single Ascending Dose Study of MK-1092 in Healthy Participants and in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-1092-001) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Euglycemic clamp with Humalog® and Lantus® CI brief — competitive landscape report
- Euglycemic clamp with Humalog® and Lantus® updates RSS · CI watch RSS
- Adocia portfolio CI
Frequently asked questions about Euglycemic clamp with Humalog® and Lantus®
What is Euglycemic clamp with Humalog® and Lantus®?
Euglycemic clamp with Humalog® and Lantus® is a Small molecule drug developed by Adocia.
Who makes Euglycemic clamp with Humalog® and Lantus®?
Euglycemic clamp with Humalog® and Lantus® is developed by Adocia (see full Adocia pipeline at /company/adocia).
What development phase is Euglycemic clamp with Humalog® and Lantus® in?
Euglycemic clamp with Humalog® and Lantus® is in Phase 1.